OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis
OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis have?
OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis has 24 citations in the OpenAlex counts ScholarIQ stores.
When was OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis published?
OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis has 2021 year in the ScholarIQ index.
What is the open-access status of OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis?
OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis has bronze oa status in the ScholarIQ index.
What is the DOI of OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis?
The DOI for OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis is on the source record.
What is the PMID of OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis?
The PMID for OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis is on the source record.
What is the OpenAlex record for OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis?
The OpenAlex for OBSIDIAN – real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis is on the source record.